Lexaria Bioscience Corp. (NASDAQ: LEXX) will be presenting at the Benzinga Global Small Cap Conference taking place on December 8-9, 2021. We invite our shareholders and all interested parties to explore investment opportunities within the global small cap space.
Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/december-2021-global/.
About the Benzinga Global Small Cap Conference
The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined educational modules, take a look at a curated group of small cap investment opportunities, and connect with the global small cap audience in an intimate, virtual setting.
For more information and/or to register for the conference please visit: https://www.benzinga.com/events/small-cap/december-2021-global/.
We look forward to seeing you there.
For further information:
Lexaria Bioscience Corp.
George Jurcic
250-765-6424, ext 202
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.lexariabioscience.com
| Last Trade: | US$0.91 |
| Daily Change: | 0.12 14.78 |
| Daily Volume: | 178,224 |
| Market Cap: | US$17.800M |
August 14, 2025 July 28, 2025 July 23, 2025 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
